skip to primary navigationskip to content

Kevin Brindle's lab in new collaboration with Medimmune

last modified Mar 12, 2014 04:22 PM
The global biologics research and development arm of AstraZeneca will contribute both funding and a post-doctoral scientist to work within the laboratory of Kevin Brindle  in the area of tumour targeted therapies. Read the full story on the main University news web site.